Grünenthal
Grünenthal is a global pharmaceutical company headquartered in Aachen, Germany, specializing in pain management and related diseases.
- Locations
- Spain only
- Work style
- Mostly hybrid (2 of 3)
- Level
- Senior+ for 2 of 3
Oligonucleotide Design Lead (f/m/d)
Global Health Economics & Outcomes Research Lead (m/f/d)
About the company
Grünenthal is a global pharmaceutical company headquartered in Aachen, Germany, specializing in pain management and related diseases. With a strong focus on research and development, the company brings innovative treatments and technologies to patients worldwide. In 2025, Grünenthal employed around 4,100 people and achieved revenues of €1.8 billion, with affiliates in 28 countries across Europe, Latin America, and the U.S.
In Spain, Grünenthal operates through its subsidiary Grünenthal Pharma, located in Madrid. The Spanish office is recognized as one of the 50 best workplaces in Spain by Great Place to Work, offering a supportive environment with excellent facilities and a prime location overlooking a park. The company actively hires for roles in research, IT, and corporate functions, making it an attractive employer for international professionals seeking opportunities in the pharmaceutical sector.
For International Professionals
- Grünenthal is headquartered in Aachen, Germany, with a significant presence in Madrid, Spain, offering opportunities for international professionals.
- The Spanish office is located in Madrid, a diverse and exciting city, and has been recognized as one of the 50 best workplaces in Spain by Great Place to Work.
- The company provides excellent facilities, including free parking and a cantina, and promotes employee well-being.
- Grünenthal operates in 28 countries, offering potential for international mobility and career growth.
- The company focuses on pain management and related diseases, with a strong R&D pipeline, providing opportunities in research and innovation.
Offices in Spain
Company History
Grünenthal is a science-based, privately-owned pharmaceutical company founded in 1946 in Aachen, Germany. It has grown through M&A and innovation to become a global leader in pain management and related diseases, with a strong focus on research and development. The company has affiliates in 28 countries across Europe, Latin America, and the U.S., and its products are available in approximately 100 countries.